Insmed Inc. buy Guggenheim
Start price
08.09.25
/
50%
€125.00
Target price
08.09.26
€146.89
Performance (%)
-27.97%
Price
29.07.26
€91.15
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -27.97%. This prediction currently runs until 08.09.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.283% | -2.283% |
| iShares Core DAX® | 1.014% | 2.699% |
| iShares Nasdaq 100 | -6.470% | -8.771% |
| iShares Nikkei 225® | -6.517% | -12.580% |
| iShares S&P 500 | -2.721% | -1.752% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at Guggenheim from $125.00 to $172.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat